Related Experiment Video
Updated: Jun 3, 2026
06:20
Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells (MSCs)
Published on: December 24, 2015
[Immunosuppression and mesenchymal stem cells: back to the future].
1Inserm U917, Faculté de médecine, Université Rennes 1,2, avenue du professeur Léon Bernard, 35043 Rennes, France.
Medecine Sciences : M/S
|March 31, 2011
Summary
Mesenchymal stem cells (MSCs) show promise for immune disorders due to their anti-inflammatory and immunosuppressive effects. Understanding their immune properties is key to improving cell therapy for conditions like graft versus host disease.
Area of Science:
- Immunology
- Regenerative Medicine
- Cell Therapy
Background:
- Mesenchymal stem cells (MSCs) are recognized for treating graft versus host disease.
- Their immune properties are critical for regenerative medicine applications.
- MSC efficiency relies on potent anti-inflammatory and immunosuppressive effects mediated by soluble factors.
Purpose of the Study:
- To elucidate the immunological mechanisms underlying MSC efficacy.
- To explore the role of MSCs in treating immune disorders.
- To understand MSC interactions with immune cells for improved therapeutic strategies.
Main Methods:
- Analysis of MSC-derived soluble factors.
- Investigation of MSC immunomodulatory properties.
- Assessment of MSC interactions with immune cell subsets.
Main Results:
- MSCs exert powerful, inducible immunosuppressive effects via soluble factors.
- Allogeneic MSCs are not immunoprivileged and have limited in vivo persistence.
- MSCs exhibit a "touch-and-go" effect involving direct immune cell interaction and modulation.
Conclusions:
- Understanding MSC immunology is crucial for optimizing cell therapy.
- MSC immunoregulatory properties are key to their therapeutic potential.
- Further research into MSC mechanisms will enhance clinical applications.
Related Concept Videos
01:19Mesenchymal Stem Cells
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
01:40Cell-mediated Immune Responses
Overview
01:28Forced Transdifferentiation
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial transdifferentiation occurs...
Artificial transdifferentiation occurs...